Role of nitric oxide in regulation of coronary blood flow during myocardial ischemia in dogs

Journal of the American College of Cardiology

Volumn 27, Issue 7, 1996, Pages 1804-1812

  Kitakaze, Masafumi ^a   Node, Koichi ^a   Minamino, Tetsuo ^a   Kosaka, Hiroaki ^a   Shinozaki, Yoshiro ^b   Mori, Hidezo ^b   Inoue, Michitoshi ^c   Hori, Masatsugu ^a   Kamada, Takenobu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYCLIC GMP; ENDOTHELIUM DERIVED RELAXING FACTOR; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRITE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY HEMODYNAMICS; CORONARY VASCULAR RESISTANCE; DOG; EXTRACORPOREAL CIRCULATION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; NONHUMAN; PRIORITY JOURNAL;

EID: 0029889025     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00064-2     Document Type: Article

References (42)

1. Berne RM. The role of adenosine in the regulation of coronary blood flow. Cire Res 1980;47:807-13.
2. Feigl EO. Coronary physiology. Physiol Rev 1983;63:1-205.
3. Hori M, Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension 1991;18:565-74.
4. Bassenge E, Heusch G. Endothelial and neuro-humoral control of coronary blood flow in health and disease. Rev Physiol Biochem Pharmacol 1990;116: 77-165.
5. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-9.
6. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide from L-arginine. Nature 1987;327:524-6.
7. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Toxicol 1990;30:535-60.
8. Pohl U, Busse R. Hypoxia stimulates release of endothelium-derived relaxant factor. Am J Physiol 1989;256:H1595-600.
9. Park KH, Rubin LE, Gross SS, Levi RG. Nitric oxide is a mediator of hypoxic coronary vasodilation. Relation to adenosine and cyclooxygenase-derived metabolites. Circ Res 1992;71:992-1001.
10. Kostic MM, Schrader J. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res 1992;70:208-12.
11. Yamabe H, Okumura K, Ishizaka H, Tsuchida T, Yasue H. Role of endothelium-derived nitric oxide in myocardial reactive hyperemia. Am J Physiol 1992;263:H8-14.
12. Duncker DJ, Bache RJ. Inhibition of nitric oxide production aggravates myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis. Circ Res 1994;74:629-40.
13. G-monomethyl L-arginine inhibits endothelium-derived relaxing factor-stimulated cyclic GMP accumulation in cocultures of endothelial and vascular smooth muscle cells by an action specific to the endothelial cell. Circ Res 1990;67:979-85.
14. W-nitro-L-arginine methyl ester in the cat. Circ Res 1992;70:364-9.
15. Acad BA, Joselevitz-Goldman J, Scholz PM, Weiss HR. Improved distribution of regional oxygenation in denervated ischemic dog myocardium. Circ Res 1988;62:1041-8.
16. 2-adrenoceptor activity on ischemic myocardium during coronary hypoperfusion in dogs. Circ Res 1989;65:1632-45.
17. Abel FL. Maximal negative dP/dt as an indicator of end of systole. Am J Physiol 1981;240:H676-9.
18. Bergmeyer HU. Methods of Enzymatic Analysis. New York: Academic Press 1963;266-70.
19. 1-adrenoceptor partial agonist xamoterol in relation to plasma norepinephrine levels during exercise in patients with left ventricular dysfunction. Circulation 1987;75:213-20.
20. 15N]nitrate in biological fluids. Anal Biochem 1982;126: 131-8.
21. Kosaka H, Tsuda M, Kurashima Y, et al. Marked nitration by stimulation with lipopolysaccaride in ascorbic acid-deficient rats. Carcinogenesis 1990; 11:1887-9.
22. Node K, Kitakaze M, Kosaka H, et al. Plasma nitric oxide end products are increased in the ischemic canine heart. Biochem Biophys Res Commun 1995;211:370-4.
23. Steiner AL, Parker CW, Kipnis DM. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibody and iodinated cyclic nucleotides. J Biol Chem 1972;247:1106-13.
24. Steiner AL, Pagliara AS, Chase LR, Kipnis DM. Radioimmunoassay for cyclic nucleotides. II. Adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in mammalian tissues and body fluids. J Biol Chem 1972; 247:1114-20.
25. Honma M, Satoh T, Takezawa J, Ui M. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samplings from blood and tissue. Biochem Med 1977;18:257-73.
26. Mori H, Haruyama S, Shinozaki Y, et al. New nonradioactive microspheres and more sensitive x-ray fluorescence to measure regional blood flow. Am J Physiol 1992;263:H1946-57.
27. Snedecor GW, Cochran WG. Statistical Methods. Ames (IA): Iowa State University Press, 1972:258-98.
28. Steel RGD, Torrie JH. Principle and Procedures of Statistics: A Biomedical Approach. 2nd ed. New York: McGraw-Hill 1980;137-238.
29. Kelm M, Schrader J. Nitric oxide release from the isolated guinea pig heart. Eur J Pharmacol 1988;155:317-21.
30. Steward DJ, Holtz J, Pohl U, Bassenge E. Balance between endothelium-mediated dilating and direct constricting actions of serotonin on resistance vessels in the isolated rabbit heart. Eur J Pharmacol 1987;143:131-4.
31. Brutsaert DL, Meulemans AL, Spido KR, Sys SU. Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ Res 1988;62:358-66.
32. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signalling system. Proc Natl Acad Sci USA 1993;90:347-51.
33. Cohen RA, Weisbrod RM. Endothelium inhibits norepinephrine release from adrenergic nerves of rabbit carotid artery. Am J Physiol 1988;254: H871-8.
34. Sneddon JM, Vane JR. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci USA 1988;85: 2800-4.
35. Komamura K, Node K, Kosaka H, Inoue M. Endogenous nitric oxide inhibits microthromboembolism in the ischemic heart [Abstract]. Circulation 1994;90 Suppl I:I-345.
36. Griffith TM, Edwards DH, Lewis MJ, Newby AC, Henderson AH. The nature of endothelium-derived vascular relaxant factor. Nature 1984;308:645-7.
37. Kitakaze M, Node K, Komamura K, et al. Evidence for nitric oxide generation in the cardiomyocytes: its augmentation by hypoxia. J Mol Cell Cardiol 1995;27:1249-54.
38. Egashira K, Inou T, Hirooka Y, et al. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factor and proximal atherosclerotic lesions. J Clin Invest 1993;91:29-37.
39. Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction: potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 1992;85:1927-38.
40. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990;81:1762-7.
41. Martorana PA, Kettenbach B, Breipohl G, Linz W, Scholkens BA. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol 1990;182:395-6.
42. Kitakaze M, Minamino T, Node K, et al. Beneficial effects of inhibition of angiotensin converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs. Circulation 1995;92:950-61.